We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.75 | 34.50 | 35.00 | 34.75 | 34.75 | 34.75 | 29,712 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.66 | 125.53M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/7/2020 12:55 | Great opportunity to top up. | lhoskins | |
15/7/2020 09:46 | Been adding a few here. | someuwin | |
13/7/2020 13:56 | getting walked back down into the valleys. | edwardt | |
06/7/2020 09:43 | Yes, especially as HOYA group (£30bn valuation) already holds over 3% of CREO. "...David Woods, Non-Executive Director, has been appointed as Chief Commercial Officer ('CCO'), with effect from 1 August 2020. David has extensive experience in the med-tech sector and joins the Company in his new full-time executive role based in the USA, having previously been the President and CEO of PENTAX Americas and M&A Director of HOYA Group PENTAX Medical." | someuwin | |
06/7/2020 09:12 | Guy has a big background in M&A .. just seems like Creo is getting lined up for a suitor | dplewis1 | |
06/7/2020 08:31 | Another hugely positive RNS today. | someuwin | |
02/7/2020 11:17 | The clear advantage of this tech is that you can kill the virus / sterilize objects / people / rooms etc using a plasma mist without actually making contact with them. And it looks from the video that they have serval product ideas taking shape already... Mist Sterilizer Plasma portal Plasma Hand Sterilizer Mobile PPE / Equipment Sterilizer Plasma Wand Plasma Endoscopic Sterilizer | someuwin | |
02/7/2020 10:45 | This looks amazing! Check out the video... Creo Medical's Cool Plasma Technology This is "Creo Medical's Cool Plasma Technology" by Creo Medical | someuwin | |
02/7/2020 10:25 | A few buys trickling through now after some earlier sells. | azuli | |
02/7/2020 08:38 | ...It's always quiet here. But CREO are quietly building a monster company - imo. | someuwin | |
02/7/2020 08:34 | Grabbed a few of these. Quiet start so far. | azuli | |
02/7/2020 07:19 | "...Creo's Cool Plasma technology has a proven, high efficacy kill of bacteria, and is expected to be highly effective in the inactivation of viruses. 6 log (i.e. 99.9999%) kill has been shown on the most resilient bacteria, including MRSA. E.Coli, K.Pneumoniae and C. difficile. Initial research and third party testing indicates a consistent view that Creo's Cool Plasma would inactivate (kill) the SARS-CoV-2 virus given its performance on relatively 'tougher' bacteria. End market applications are wide but would be initially focused on COVID-19 urgent needs including virus inactivation (sterilisation) inside the working (instrument) channel of endoscopes, on PPE, hospital equipment (ventilators), personal sanitisation, dentistry and the environmental decontamination including beds, rooms, wards, ambulances and other areas. Creo's Cool Plasma technology is covered by strong IP including patents and the Company has developed a number of prototype working devices and amassed scientific evidence, working with partners including University College Hospital (London) ; University of the West of England (Bristol), National Institute for Health Research, The Griffin Institute at Northwick Park (formerly NPIMR)." | someuwin | |
02/7/2020 07:11 | This is very interesting, I'm not sure why they need the 2m loan as they have loads of cash but the product sounds like it can be used in loads of situations. | dplewis1 | |
02/7/2020 07:05 | Wow - big news today! Creo Medical Group plc ("Creo" or the "Company") Development loan for plasma sterilising product CREO advanced energy platform to combat COVID-19... | someuwin | |
01/7/2020 14:56 | Creo Medical is cited as a Case Study in the Govts UK R&D Roadmap page 29. And we all know politicians like to back winners. | drbob_ceng | |
30/6/2020 11:25 | Yeah I noticed that too, good little bounce today as well. | dplewis1 | |
30/6/2020 11:04 | Good to see on Twitter that their speedboat courses are back up and running | someuwin | |
27/6/2020 17:22 | CREO MC @2.06p £324.5M Lossmaking:last time loss of £15.9M next ann due: 30.9.20 half year raised 4.12.19 £50M @ 180p a share Shouldn't touch it with a barge pole, because it has lots of time to revisit 180p and below and there are no compelling reasons to invest at the moment! | a1samu | |
25/6/2020 13:09 | I've seen some stuff on research tree from Cenkos but that's it | dplewis1 | |
25/6/2020 13:06 | Anyone know which sell side firms covers creo? | edwardt | |
23/6/2020 13:57 | AGM tomorrow. Not expecting an update - but you never know. | someuwin | |
23/6/2020 12:32 | These GI (gastro-intestinal) medical devices are just the start. CREO's ambitions are much, much bigger. | someuwin | |
22/6/2020 11:38 | Nice interview with the founder too, Prof Chris. | drbob_ceng |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions